+++
title = "Figure S3"
date = "2019-01-24"
author = "Lukasz Migas"
cover = ""
description = "Figure S3 - Mass spectra for the NIST mAb standard"
+++

## Figure caption

Mass spectra for the NIST mAb standard (a) fully glycosylated (intact), (b) following endoS2 treatment (truncated glycans) and (c) following PNGase F treatment (fully deglycosylated) 

[Open in another tab](https://upton-herceptin-2019.netlify.app/assets/Figure_S3.html)

## Interactive figure

<iframe
    width="1150"
    frameborder="0"
    height="1200"
    src="https://upton-herceptin-2019.netlify.app/assets/Figure_S3.html"
    style="background: #FFFFFF;"
></iframe>

## Reference

[Upton R, Migas LG, Pacholarz KJ, Beniston RG, Estdale S, Firth D, Barran PE.Hybrid mass spectrometry methods reveal lot-to-lot differences and delineate the effects of glycosylation on the tertiary structure of HerceptinÂ®. Chem. Sci. Advance Article (2019).](https://pubs.rsc.org/en/content/articlepdf/2019/sc/c8sc05029e)